367 related articles for article (PubMed ID: 15096505)
1. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
[TBL] [Abstract][Full Text] [Related]
2. Reduced level of ribonucleotide reductase R2 subunits increases dependence on homologous recombination repair of cisplatin-induced DNA damage.
Lin ZP; Lee Y; Lin F; Belcourt MF; Li P; Cory JG; Glazer PM; Sartorelli AC
Mol Pharmacol; 2011 Dec; 80(6):1000-12. PubMed ID: 21875941
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells.
Håkansson P; Hofer A; Thelander L
J Biol Chem; 2006 Mar; 281(12):7834-41. PubMed ID: 16436374
[TBL] [Abstract][Full Text] [Related]
4. Excess ribonucleotide reductase R2 subunits coordinate the S phase checkpoint to facilitate DNA damage repair and recovery from replication stress.
Lin ZP; Belcourt MF; Carbone R; Eaton JS; Penketh PG; Shadel GS; Cory JG; Sartorelli AC
Biochem Pharmacol; 2007 Mar; 73(6):760-72. PubMed ID: 17188250
[TBL] [Abstract][Full Text] [Related]
5. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
[TBL] [Abstract][Full Text] [Related]
6. Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein.
Kunos CA; Chiu SM; Pink J; Kinsella TJ
Radiat Res; 2009 Dec; 172(6):666-76. PubMed ID: 19929413
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers.
Kunos CA; Radivoyevitch T; Pink J; Chiu SM; Stefan T; Jacobberger J; Kinsella TJ
Radiat Res; 2010 Nov; 174(5):574-81. PubMed ID: 20954859
[TBL] [Abstract][Full Text] [Related]
8. Caspase-dependent Proteolysis of Human Ribonucleotide Reductase Small Subunits R2 and p53R2 during Apoptosis.
Tebbi A; Guittet O; Tuphile K; Cabrié A; Lepoivre M
J Biol Chem; 2015 May; 290(22):14077-90. PubMed ID: 25878246
[TBL] [Abstract][Full Text] [Related]
9. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells.
Guittet O; Håkansson P; Voevodskaya N; Fridd S; Gräslund A; Arakawa H; Nakamura Y; Thelander L
J Biol Chem; 2001 Nov; 276(44):40647-51. PubMed ID: 11517226
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
[TBL] [Abstract][Full Text] [Related]
11. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
[TBL] [Abstract][Full Text] [Related]
12. Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.
Azimi A; Majidinia M; Shafiei-Irannejad V; Jahanban-Esfahlan R; Ahmadi Y; Karimian A; Mir SM; Karami H; Yousefi B
Gene; 2018 Feb; 642():249-255. PubMed ID: 29126924
[TBL] [Abstract][Full Text] [Related]
13. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
Huang A; Fan H; Taylor WR; Wright JA
Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
[TBL] [Abstract][Full Text] [Related]
16. Glutathione-glutaredoxin is an efficient electron donor system for mammalian p53R2-R1-dependent ribonucleotide reductase.
Sengupta R; Coppo L; Mishra P; Holmgren A
J Biol Chem; 2019 Aug; 294(34):12708-12716. PubMed ID: 31266802
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.
Kuo ML; Hwang HS; Sosnay PR; Kunugi KA; Kinsella TJ
Cancer J; 2003; 9(4):277-85. PubMed ID: 12967138
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide.
Guittet O; Tebbi A; Cottet MH; Vésin F; Lepoivre M
Nitric Oxide; 2008 Sep; 19(2):84-94. PubMed ID: 18474260
[TBL] [Abstract][Full Text] [Related]
19. A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity.
Crona M; Codó P; Jonna VR; Hofer A; Fernandes AP; Tholander F
Mol Oncol; 2016 Nov; 10(9):1375-1386. PubMed ID: 27511871
[TBL] [Abstract][Full Text] [Related]
20. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
Devlin HL; Mack PC; Burich RA; Gumerlock PH; Kung HJ; Mudryj M; deVere White RW
Mol Cancer Res; 2008 May; 6(5):808-18. PubMed ID: 18505925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
